Jazz Pharmaceuticals (JAZZ) Shares Outstanding (Weighted Average) (2010 - 2026)

Jazz Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $61.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.48% year-over-year to $61.9 million; the TTM figure through Mar 2026 stood at $61.9 million (up 1.48% YoY), while the FY2025 annual figure was $61.0 million, down 1.39% from the prior year.
• Shares Outstanding (Weighted Average) was $61.9 million for Q1 2026 at Jazz Pharmaceuticals, up from $61.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $63.7 million in Q2 2023 to a low of $60.7 million in Q3 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $62.2 million across 5 years, with a median of $62.2 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) climbed 9.56% in 2022, then dropped 2.69% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $62.5 million in 2022, then grew by 1.2% to $63.3 million in 2023, then slipped by 2.3% to $61.8 million in 2024, then declined by 1.39% to $61.0 million in 2025, then gained by 1.51% to $61.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $61.9 million (Q1 2026), $61.0 million (Q4 2025), and $60.7 million (Q3 2025), per Business Quant data.